Mark Akin, MD
Obstetrics & Gynecology · Austin, TXNPI 1871512475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.6% of the total across 304 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,359 and has fallen 54.8% since, to $1,065 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 304 payments — averaging $32.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Asensus Surgical, Inc.$1K
- AbbVie$900
- Dysis Medical, Inc.$554
- Sumitomo Pharma America, Inc.$551
- Coloplast$452
- plus $4K from 37 others
Across 44 payments — averaging $2953.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$79K
- Ferring International Pharmascience Center US$18K
- GSK$16K
- Bayer$11K
- AbbVie$5K
What the payments were for
- Travel & lodging$8388%
- Food & beverage$9,11092%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 64 | $1,938 |
| Asensus Surgical, Inc. | 10 | $1,443 |
| AbbVie | 41 | $900 |
| Dysis Medical, Inc. | 7 | $554 |
| Sumitomo Pharma America, Inc. | 33 | $551 |
| Coloplast | 8 | $452 |
| Therapeuticsmd, Inc. | 18 | $342 |
| Shield Therapeutics Inc | 4 | $304 |
| Astellas Pharma US Inc | 15 | $297 |
| Medtronic | 4 | $275 |
| Lupin Inc. | 12 | $255 |
| Minerva Surgical, Inc | 2 | $218 |
| Hologic Sales And Service, LLC | 9 | $201 |
| Axonics, Inc. | 2 | $197 |
| Daiichi Sankyo Inc. | 9 | $184 |
| Biogen | 10 | $181 |
| Covidien LP | 1 | $162 |
| Innovation Technologies Inc | 1 | $132 |
| Pacira Pharmaceuticals Incorporated | 1 | $122 |
| Olympus America Inc. | 2 | $121 |
| Exeltis, USA Inc. | 7 | $112 |
| Teleflex LLC | 1 | $105 |
| Procept Biorobotics Corporation | 1 | $101 |
| Evofem Biosciences, Inc. | 5 | $96 |
| Lilly USA, LLC | 3 | $77 |
| Mayne Pharma Commercial LLC | 3 | $68 |
| Avion Pharmaceuticals | 4 | $68 |
| Currax Pharmaceuticals LLC | 4 | $63 |
| Johnson & Johnson | 2 | $49 |
| IBSA Pharma Inc. | 3 | $47 |
| Exact Sciences | 2 | $45 |
| Pfizer | 2 | $40 |
| Boston Scientific | 1 | $36 |
| Organon | 2 | $31 |
| Amgen | 2 | $28 |
| Aspira Women's Health Inc | 2 | $26 |
| SRS Medical Systems, Inc. | 1 | $24 |
| Myovant Sciences Inc. | 1 | $21 |
| Coopersurgical, Inc. | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Millicent US Inc | 1 | $16 |
| KCI USA, Inc. | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senhance Surgical Robotics System$1,278
- DYSIS V3 DIGITAL COLPOSCOPE$769
- DYSIS v3 Digital Coploscope$726
- DYSIS Ultra$498
- DYSIS Ultra 2.0$498
- Wegovy$348
- Autosuture$274
- Saxenda$243
- ALTIS$168
- Irrisept$132
- EXPAREL$122
- Axonics$117
- RYBELSUS$117
- BIJUVA$113
- SOLOSEC$110
- Synthroid$106
- UroLift$105
- ACCRUFER$104
- AQUABEAM SYSTEM$101
How this compares
$9,948 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $23,609 |
| MyrbetriqMirabegron | 18 | $16,220 |
| ProgesteroneProgesterone, Micronized | 117 | $4,126 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,665 |
| ValacyclovirValacyclovir Hcl | 34 | $1,663 |
| Estradiol | 27 | $1,115 |
| Levothyroxine Sodium | 92 | $631 |
| Atorvastatin Calcium | 17 | $185 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 13 | $164 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $145 |
| Acyclovir | 11 | $143 |
| Montelukast Sodium | 11 | $127 |
| Hydrochlorothiazide | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,938 | $23,60925 claims |
| Astellas Pharma US IncMyrbetriq | $297 | $16,22018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Renu ChalasaniAustin$156K
- Sharyl Brasher-GilesAustin$42K
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.